Abstract
OBJECTIVE--To compare the efficacy and safety of terbinafine 1% cream and clotrimazole 1% cream in the treatment of tinea pedis. DESIGN--Multicentre, double blind parallel group study. SETTING--32 general practices and one hospital. PATIENTS--256 patients with mycologically confirmed tinea pedis. Of the 211 patients evaluable, 107 were randomised to terbinafine (75 male, 32 female; mean (range) age 40 (12-81) years) and 104 to clotrimazole (79 male, 25 female; mean (range) age 36 (12-71) years). INTERVENTIONS--Terbinafine 1% cream applied twice daily for one week and inert cream applied twice daily for the next three weeks. Clotrimazole 1% cream applied twice daily for four weeks. MAIN OUTCOME MEASURES--Mycological cure (negative results on microscopy and culture) and effective treatment (mycological cure plus no or minimal signs and symptoms) measured at weeks 1, 2, 3, 4, and 6. RESULTS--At week four rates of mycological cure were 93.5% for terbinafine and 73.1% for clotrimazole (p = 0.0001); and at week six 97.2% for terbinafine and 83.7% for clotrimazole (p = 0.001). Rates of effective treatment at week 4 were 89.7% for terbinafine and 58.7% for clotrimazole (p = 0.0001); and 89.7% for terbinafine and 73.1% for clotrimazole (p = 0.002) at week 6. CONCLUSION--These results indicate that a one week course of terbinafine 1% cream is more effective in the treatment of tinea pedis than a four week course of clotrimazole 1% cream, both in terms of mycological cure and effective treatment.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berman B., Ellis C., Leyden J., Lowe N., Savin R., Shupack J., Stiller M., Tschen E., Zaias N., Birnbaum J. E. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials. J Am Acad Dermatol. 1992 Jun;26(6):956–960. doi: 10.1016/0190-9622(92)70141-2. [DOI] [PubMed] [Google Scholar]
- Clayton Y. M. In vitro activity of terbinafine. Clin Exp Dermatol. 1989 Mar;14(2):101–103. doi: 10.1111/j.1365-2230.1989.tb00901.x. [DOI] [PubMed] [Google Scholar]
- Greer D. L., Jolly H. W., Jr Treatment of tinea cruris with topical terbinafine. J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):800–804. doi: 10.1016/0190-9622(90)70292-p. [DOI] [PubMed] [Google Scholar]
- Griffiths C. E., Fisher G. J., Finkel L. J., Voorhees J. J. Mechanisms of action of retinoic acid in skin repair. Br J Dermatol. 1992 Sep;127 (Suppl 41):21–24. doi: 10.1111/j.1365-2133.1992.tb16983.x. [DOI] [PubMed] [Google Scholar]
- Hill S., Thomas R., Smith S. G., Finlay A. Y. An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream. Br J Dermatol. 1992 Oct;127(4):396–400. doi: 10.1111/j.1365-2133.1992.tb00461.x. [DOI] [PubMed] [Google Scholar]
- Millikan L. E. Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris. J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):795–799. doi: 10.1016/0190-9622(90)70291-o. [DOI] [PubMed] [Google Scholar]
- Petranyi G., Meingassner J. G., Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother. 1987 Sep;31(9):1365–1368. doi: 10.1128/aac.31.9.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sud I. J., Feingold D. S. Mechanisms of action of the antimycotic imidazoles. J Invest Dermatol. 1981 Jun;76(6):438–441. doi: 10.1111/1523-1747.ep12521036. [DOI] [PubMed] [Google Scholar]
- Villars V., Jones T. C. Clinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol. 1989 Mar;14(2):124–127. doi: 10.1111/j.1365-2230.1989.tb00908.x. [DOI] [PubMed] [Google Scholar]